Carbapenem antibiotic compounds
AssigneeZeneca Limited
InventorsMichael J. Betts, Michael L. Swain
Life of this patent
Estimating the term…
Loading patent…
AssigneeZeneca Limited
InventorsMichael J. Betts, Michael L. Swain
Estimating the term…
A carbapenem compound of the formula (I) ##STR1## wherein: R.sup.1 is 1-hydroxyethyl, 1-fluoroethyl or hydroxymethyl; R.sup.2 is hydrogen or C.sub.1-4 alkyl; R.sup.3 is hydrogen or C.sub.1-4 alkyl; R.sup.4 is hydroxy or carboxy; and the phenyl ring is optionally further substituted by one or two substituents selected from halo, cyano, C.sub.1-4 alkyl, nitro, hydroxy, carboxy, C.sub.1-4 alkoxy, trifluoromethyl, C.sub.1-4 alkoxycarbonyl, carbamoyl, C.sub.1-4 alkylcarbamoyl, di-C.sub.1-4 alkylcarbamoyl, amino, C.sub.1-4 alkylamino, di-C.sub.1-4 alkylamino sulphonic acid, C.sub.1-4 alkylS(O).sub.n --(wherein n is 0-2), N-C.sub.1-4 alkanesulphonamido, C.sub.1-4 alkanoylamino and C.sub.1-4 alkanoyl(N-C.sub.1-4 alkyl)amino: provided that the phenyl ring is substituted by at least one carboxy; or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof.
A carbapenem compound of the formula (I) ##STR16## wherein:
A carbapenem compound of formula (I):
A compound of the formula (V):
A method of treatment of a bacterial infection by administering to a patient in need thereof an antibacterially effective amount of a carbapenem compound of formula (I):
Dependencies are inferred from the claim text.